Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEM-P vs CHOP in First-Line T-cell Lymphoma
NCT01719835Phase 2Unknown
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Mar 2012
- Primary completion
- Nov 2016
- Modality
- Nanoparticles, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, Cisplatin micelle injection (HA132), methylprednisolone injection in T-cell lymphoma, sponsored by Royal Marsden NHS Foundation Trust. Status: unknown.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)methylprednisolone injection
03
Conditions
T-cell lymphoma
Beyond the preview
Go deeper on NCT01719835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01719835.